KR102276379B9 - IF1 (ATPase inhibitory factor 1)을 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학 조성물 - Google Patents

IF1 (ATPase inhibitory factor 1)을 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학 조성물

Info

Publication number
KR102276379B9
KR102276379B9 KR1020190116679A KR20190116679A KR102276379B9 KR 102276379 B9 KR102276379 B9 KR 102276379B9 KR 1020190116679 A KR1020190116679 A KR 1020190116679A KR 20190116679 A KR20190116679 A KR 20190116679A KR 102276379 B9 KR102276379 B9 KR 102276379B9
Authority
KR
South Korea
Prior art keywords
preventing
composition
inhibitory factor
bone diseases
treating bone
Prior art date
Application number
KR1020190116679A
Other languages
English (en)
Other versions
KR20200038411A (ko
KR102276379B1 (ko
Inventor
신민정
김현수
정인혁
정지형
Original Assignee
고려대학교 산학협력단
차의과학대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고려대학교 산학협력단, 차의과학대학교 산학협력단 filed Critical 고려대학교 산학협력단
Publication of KR20200038411A publication Critical patent/KR20200038411A/ko
Application granted granted Critical
Publication of KR102276379B1 publication Critical patent/KR102276379B1/ko
Publication of KR102276379B9 publication Critical patent/KR102276379B9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020190116679A 2018-10-02 2019-09-23 IF1 (ATPase inhibitory factor 1)을 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학 조성물 KR102276379B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180117693 2018-10-02
KR20180117693 2018-10-02

Publications (3)

Publication Number Publication Date
KR20200038411A KR20200038411A (ko) 2020-04-13
KR102276379B1 KR102276379B1 (ko) 2021-07-14
KR102276379B9 true KR102276379B9 (ko) 2022-03-15

Family

ID=70224630

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190116679A KR102276379B1 (ko) 2018-10-02 2019-09-23 IF1 (ATPase inhibitory factor 1)을 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학 조성물

Country Status (1)

Country Link
KR (1) KR102276379B1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230092461A (ko) 2021-12-17 2023-06-26 고려대학교 산학협력단 코돈 최적화된 atpif1 폴리뉴클레오티드 및 이를 포함하는 재조합 벡터

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034833A2 (en) * 1999-11-10 2001-05-17 Mitokor Regulating endogenous inhibitor at atp synthase
US20150065556A1 (en) * 2013-08-05 2015-03-05 Whitehead Institute For Biomedical Research Therapeutic targets for mitochondrial disorders
KR20150026517A (ko) * 2013-09-03 2015-03-11 한림대학교 산학협력단 호장근 추출물을 함유하는 골다공증 치료 및 예방용 조성물
KR101941975B1 (ko) * 2017-03-17 2019-01-25 고려대학교 산학협력단 Atpif1을 함유하는 당뇨 치료용 약학조성물

Also Published As

Publication number Publication date
KR20200038411A (ko) 2020-04-13
KR102276379B1 (ko) 2021-07-14

Similar Documents

Publication Publication Date Title
IL285782A (en) Compounds, compositions, and methods for treating disease
ZA202006610B (en) Compositions for the treatment of skin conditions
ZA202007055B (en) Compositions for the treatment of skin conditions
IL287796A (en) Preparations and methods for the treatment of diseases mediated by ATPase
EP3818085A4 (en) COMPOSITIONS AND THEIR USES FOR THE TREATMENT OF DISEASES OR DISORDERS
EP4000609A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF BONE DISEASES
EP3827837A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF IMMUNE DISEASES
KR102239075B9 (ko) IF1 (ATPase inhibitory factor 1)을 유효성분으로 함유하는 근감소증의 예방 또는 치료용 약학 조성물
EP4058041C0 (en) COMPOSITION FOR THE TREATMENT OF EPITHELIAL LESIONS
IL289687A (en) Preparations for the treatment of hair loss
KR102239074B9 (ko) IF1 (ATPase inhibitory factor 1)을 유효성분으로 함유하는 비만의 예방 또는 치료용 약학 조성물
KR102276379B9 (ko) IF1 (ATPase inhibitory factor 1)을 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학 조성물
PT3810128T (pt) Composições para tratar e/ou prevenir doenças de agregação de proteinas
KR102526197B9 (ko) Cotl1을 유효성분으로 포함하는 골질환 진단, 예방 또는 치료용 조성물
ZA202107235B (en) Compositions and methods for treating ocular disease
ZA202007616B (en) Pharmaceutical composition for preventing or treating aids comprising rhodanine derivative
EP3925623A4 (en) MEDICINAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BONE DISEASES
EP3852820A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF BONE INJURIES
IL276228A (en) Compounds and preparations for the treatment of pain
KR102316727B9 (ko) 아토피성 질환 예방 또는 치료용 약학적 조성물
GB201908076D0 (en) Skin treatment composition
PL3773641T3 (pl) Kompozycje farmaceutyczne do stosowania miejscowego w leczeniu dolegliwości skórnych
PL3758799T3 (pl) Kompozycja do zapobiegania i traktowania uszkodzeń skóry spowodowanych fotoekspozycją
EP4000622A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF BONE DISEASES
KR102295111B9 (ko) 대사성 골질환 또는 갱년기 증상 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]